Calcium and Magnesium Supplementation Improves Serum OPG/RANKL in Calcium-Deficient Ovariectomized Rats.
Magnesium (Mg) deficiency has been reported to result in increases in bone resorption through changes in the cytokine system, such as decreases in serum osteoprotegerin (OPG) concentrations and increases in receptor activator of NF-κB ligand (RANKL) concentrations. However, there are few data about the effects of Mg supplementation on OPG and RANKL. This study was carried out to investigate the effects of Mg supplementation on bone mineral density (BMD), bone mineral content (BMC), serum OPG, and RANKL in ovariectomized (OVX) rats relative to calcium (Ca) intake levels. Fifty-five Sprague-Dawley female rats were divided into the following five groups and fed for 12 weeks as indicated: sham-operated control group (sham), OVX Ca-deficient group (OLCa, 0.1% Ca and 0.05% Mg), OVX Ca-deficient and Mg-supplemented group (OLCaMg, 0.1% Ca and 0.1% Mg), OVX Ca-adequate group (OACa, 0.5% Ca and 0.05% Mg), and OVX Ca-adequate and Mg-supplemented group (OACaMg, 0.5% Ca and 0.1% Mg). The BMD of the lumbar spine, femur, and tibia in the OVX groups was significantly lower than that in the sham group. The OVX group with an adequate-Ca diet showed significantly higher BMC of the lumbar spine compared to the low Ca-diet group regardless of Mg supplementation. The OACaMg group had significantly higher levels of OPG and OPG/RANKL ratio than did the OLCa group. From the above results, it is still unclear whether Mg supplementation can improve bone mineral status, while Mg supplementation with an adequate-Ca diet resulted in a change in cytokines that may promote bone formation.
Bae
Yun Jung
YJ
Department of Food and Nutrition, Sookmyung Women's University, Seoul, South Korea. swingtru@hanmail.net
Kim
Mi-Hyun
MH
D000818:Animals; D015519:Bone Density / Q000187:drug effects; D002118:Calcium / Q000097:blood / Q000172:deficiency*; D002119:Calcium Carbonate / Q000008:administration & dosage*; D002136:Calcium, Dietary; D003677:Deficiency Diseases / Q000097:blood / Q000178:diet therapy*; D004357:Drug Synergism; D005260:Female; D008277:Magnesium Oxide / Q000008:administration & dosage*; D053244:Osteoprotegerin / Q000097:blood*; D010052:Ovariectomy; D053245:RANK Ligand / Q000097:blood*; D051381:Rats; D017207:Rats, Sprague-Dawley
D002136:Calcium, Dietary; D053244:Osteoprotegerin; D053245:RANK Ligand; C506032:Tnfrsf11b protein, rat; D008277:Magnesium Oxide; D002119:Calcium Carbonate; D002118:Calcium